Shortcast over Coffee Conversations : Murali Neelakantan Looks at Indian Pharma
Sep 24, 2023
Murali Neelakantan, former Global General Counsel at Cipla, discusses the poor quality of manufacturing sites in the Indian pharmaceutical industry and the need for stricter regulation. Topics include the use of fillers in tablets, controversies surrounding generic prescriptions, lack of scientific basis for Ayurvedic products, and lack of accountability in vaccine-related deaths. The podcast also explores the disparities in regulations between the US and EU regarding chemicals in processed food.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 3min
Quality Standards and Regulatory Challenges in the Indian Pharmaceutical Industry
02:33 • 7min
Testing, Quality Control, and Fillers in Farmer Companies
10:02 • 5min
Controversy surrounding the pharmaceutical product DOLO
14:41 • 17min
Lack of Regulation and Scientific Basis for Ayurvedic Products
31:42 • 13min
Lack of Accountability and Recourse in Vaccine-Related Deaths
44:42 • 4min
Regulations and Lobbying in the Food Industry
48:23 • 8min